Skip to main
University-wide Navigation

College of Pharmacy hosting symposium on therapeutic manipulation of immune function

The College of Pharmacy  will host its 11th annual Therapeutics, Outcomes, Discovery & Delivery (TODD) Symposium from 8 a.m.–5 p.m. April 12, at the Lee T. Todd, Jr. Building.

Cannabis research center established at UK

Based within the UK College of Medicine’s Center on Drug and Alcohol Research, the UK Cannabis Center will build upon research already taking place at UK.

Why COVID-19 Vaccine Research Remains Critical

"While approved vaccines are able to prevent a COVID reinfection with a high effectiveness rate, it is still early on and we don't know how durable they are going to be in the long run. We also don’t know how effective these vaccines are at preventing asymptomatic spread. These questions are what researchers in my field will be looking at for many years to come."

COVID Vaccines: Fact Versus Fiction

Vince Venditto, PhD, assistant professor in the UK College of Pharmacy’s Department of Pharmaceutical Science, has extensive expertise in vaccine design. He was trained in organic synthesis and vaccine development. He is currently working on a clinical trial with community pharmacies to understand the prevalence of SARS-CoV-2 in Kentucky.

'Behind the Blue' - Part Three: The Vaccines to Combat a Coronavirus With Brooke Hudspeth and Vincent Venditto

In our third and final part of this interview, we ask Vince and Brooke about how this pandemic possibly ends, and how we progress into a new world after COVID-19.

'Behind the Blue' - Part Two: The Vaccines to Combat a Coronavirus With Brooke Hudspeth and Vincent Venditto

It has been nearly one year since the SARS-CoV-2 coronavirus changed the world. With millions of people infected and over a quarter-million dead in the United States, the novel coronavirus continues its pervasive hold on our health and well-being.

Creating Vaccines: How Will They Change the Pandemic?

It has been nearly one year since SARS-COV-2 (COVID-19) changed the world. With millions of people infected and over a quarter-million dead in the United States (U.S.), the novel coronavirus continues its pervasive hold on our health and well-being.

UK Study Shows FDA-approved Leukemia Drug May Help Treat Metastatic Melanoma

Building on these findings, Plattner and Markey oncologists are now collaborating with the pharmaceutical company Novartis to develop a Phase I clinical trial to test the safety and effectiveness of using nilotinib in relapsed melanoma patients.

UK College of Pharmacy Awarded $1.5 Million Grant to Accelerate Chemistry and Drug Discovery

"We need stronger and more united NMR capabilities at UK and securing funding for this new state-of-the-art NMR instrument is a first step toward achieving this important goal," Garneau-Tsodikova said.

COVID-19 Vaccine Candidate Tested at UK Shows Positive Preclinical Results

PDS0203 stands out among COVID-19 vaccines currently in development because it includes a vaccine technology pioneered by PDS Biotech called Versamune®, which stimulates important parts of the immune system to activate T cells.

Filter News